KAPSELFORMULIERUNGEN

Patent europeic · EP4233850 · En vigur

Inscripziun en il register

Numer da publicaziun
EP4233850
Numer da la dumonda
EP23160271
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
27-11-2019
Publitgà
30-08-2023
Concedì
02-10-2024
La protecziun finescha il pli tard
26-11-2039
Proxima taxa annuala scadenta
30-11-2026
Classas IPC
A61K 9/48 (2006.01)
A61K 31/451 (2006.01)
A61K 47/10 (2017.01)
A61K 47/14 (2017.01)
A61K 47/40 (2006.01)
A61K 47/44 (2017.01)
A61P 29/00 (2006.01)
Prioritad
US 201862773848 P 30.11.2018
Derivà da
EP19889873
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 01-12-2025

    Midada

    Published in Swissreg on 01.12.2025

  2. 25-06-2025

    Midada

    Published in Swissreg on 25.06.2025

  3. 03-01-2025

    Represchentant inscrit

    Representative
    Isler & Pedrazzini AG, Postfach, 8027 Zürich

    Published in Swissreg on 03.01.2025

  4. 01-12-2024

    Midada

    Published in Swissreg on 01.12.2024

  5. 03-10-2024

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 03.10.2024

Partidas

Possessur

ChemoCentryx, Inc.

One Amgen Center Drive, Thousand Oaks, CA 91320, US

Represchentant

Isler & Pedrazzini AG

Postfach, 8027 Zürich

Inventur

LELETI, Manmohan Reddy

California, 94568, US

POWERS, Jay P

California, 94044, US

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.